IEQ Capital’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,764
Closed -$442K 2205
2026
Q1
$442K Sell
1,764
-21,343
-92% -$5.31M ﹤0.01% 1362
2025
Q4
$6.36M Buy
23,107
+3,388
+17% +$927K 0.02% 464
2025
Q3
$5.17M Buy
19,719
+18,497
+1,514% +$4.5M 0.02% 477
2025
Q2
$267K Buy
1,222
+202
+20% +$43.2K ﹤0.01% 1462
2025
Q1
$228K Buy
1,020
+314
+44% +$86.5K ﹤0.01% 1312
2024
Q4
$231K Buy
+706
New +$222K ﹤0.01% 1133
2024
Q3
Sell
-1,500
Closed -$494K 1202
2024
Q2
$494K Sell
1,500
-632
-30% -$223K 0.01% 656
2024
Q1
$844K Buy
2,132
+908
+74% +$336K 0.01% 499
2023
Q4
$431K Sell
1,224
-254
-17% -$89.9K 0.01% 621
2023
Q3
$555K Buy
1,478
+34
+2% +$13.1K 0.01% 537
2023
Q2
$552K Buy
1,444
+213
+17% +$76.1K 0.01% 525
2023
Q1
$427K Buy
+1,231
New +$360K 0.01% 620
2022
Q4
Sell
-4,645
Closed -$1.14M 900
2022
Q3
$1.14M Buy
4,645
+3,821
+464% +$1.16M 0.03% 334
2022
Q2
$249K Sell
824
-473
-36% -$154K 0.01% 655
2022
Q1
$533K Buy
1,297
+113
+10% +$44.2K 0.01% 481
2021
Q4
$555K Buy
1,184
+109
+10% +$46.9K 0.01% 437
2021
Q3
$456K Buy
1,075
+317
+42% +$134K 0.01% 457
2021
Q2
$272K Buy
+758
New +$250K 0.01% 492

Other funds holding WST

IEQ Capital's WST Position: Q2 2026 in Review

IEQ Capital sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 1,764 shares — an estimated $442K sold.

IEQ Capital first reported a position in WST in Q2 2021 and held it in 18 quarters. The position peaked at $6.36M in Q4 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • IEQ Capital reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • IEQ Capital sold 1,764 West Pharmaceutical shares in Q2 2026, an estimated $442K.
  • IEQ Capital first reported a position in West Pharmaceutical in Q2 2021 and held it in 18 quarters.
  • IEQ Capital's West Pharmaceutical position peaked at $6.36M in Q4 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.